TapImmune Inc. common stock (MRKR) stock is lower by -69.46% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives MRKR stock a score of 27 out of a possible 100. That rank is influenced by a short-term technical score of 2. MRKR's rank also includes a long-term technical score of 9. The fundamental score for MRKR is 70. In addition to the average rating from Wall Street analysts, MRKR stock has a mean target price of $6.38. This means analysts expect the stock to climb 928.23% over the next 12 months.
News Home
TapImmune Inc. common stock (MRKR) Stock Has Fallen -22.50% This Week: Buy, Hold, or Sell?
Mentioned in this article
MRKR has an Overall Score of 27. Find out what this means to you and get the rest of the rankings on MRKR!